GLP-1 Desk · provider reviews
Every GLP-1 provider, scored on the facts.
We score telehealth weight-loss providers on six measurable dimensions — price transparency, state access, molecule range, onboarding speed, support responsiveness, and licensing trust — and give each one a Desk Score. Reader-supported: assume any provider we list may compensate us.
- Providers scored
- 542
- Scoring factors
- 6
- Last updated
- September 2026
Why start here before you sign up anywhere
Standing rankings
Shopping one molecule? Start here.
Most readers want one drug's shortlist, not every provider at once. On the Desk-Score rankings, partners are placed first, per our disclosure — the score itself never moves for it. The price rankings are not ordered that way: they run strictly cheapest-first, funded or not.
The Desk
Scored on: price transparency · state access · molecule range · onboarding speed · support responsiveness · licensing & trust. Assume any provider we list may compensate us — see our disclosure. Partners are placed first below; the Desk Score itself never moves for it.
- A94/100
Desk Score
One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
- Strut Health
$129/mo (see conditions) sema$149/mo (see conditions) tirz
B+89/100Desk Score
The same molecule as a lozenge or an injection, each priced on its own page — the only place in this ranking where the needle is genuinely optional.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
- Sesame Care
$149/mo (brand-name) sema$299/mo (brand-name) tirz
B+88/100Desk Score
An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.
- RxSpan MD
$249/mo sema$329/mo tirz
B+88/100Desk Score
A physician-founded desk with one of the widest menus in the ranking — compounded and brand-name GLP-1 across injectable and oral routes, microdosing, plus longevity, hair, and sexual-health lines — with transparent, all-inclusive pricing across all 50 states.
- Trimi
$175/mo sema$235/mo tirz
B+88/100Desk Score
Both molecules on one membership at a keen flat price, shipped free to all 50 states.
- Shed
$199/mo sema$299/mo tirz
B+88/100Desk Score
Widest formulation spread in the ranking — injection, liquid drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
- Eden
$198/mo sema$298/mo tirz
B+87/100Desk Score
High-disclosure compounded program — the clearest verification signals in the ranking — with a $99/mo medication price that only reads that low because the required $99/mo membership is billed separately.
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
- Pallas Health
$199/mo (see conditions) sema$299/mo (see conditions) tirz
B+87/100Desk Score
Pallas Health names all six of the pharmacies that dispense for it and two prescribing clinicians whose NPIs verify in the federal registry — then sells every GLP-1 on a single twelve-week prepay, so the advertised “/mo average” is one $597 or $897 charge divided by three.
- Sprout Health
$299/mo sema$349/mo tirz
B86/100Desk Score
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.
- HealthRX
$190/mo sema$239/mo tirz
B85/100Desk Score
A LegitScript-certified compounding platform whose pricing page prints every plan's total, per-month rate and renewal price — and whose renewals are cheaper than sign-up.
That is the top 10 of the 542 providers we score, in ranking order. The rest are scored on the same six dimensions — every review is indexed here, or compare two head-to-head on the comparison pages.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on the provider's own site. Not medical advice.
Evidence
Great sourced content, not just rankings
Every claim we publish is tied to primary research or official labeling — each piece shows its source count up front.
- 5 sources cited
Semaglutide vs Tirzepatide: Which Molecule Fits You
The two GLP-1 molecules head to head — trial weight-loss data, the single-vs-dual mechanism, and how to decide which one to ask your provider for.
- 4 sources cited
Injections vs Oral or Sublingual GLP-1: What to Know
Weekly injections carry the trial-grade weight-loss evidence; oral and sublingual GLP-1 trade some data for convenience. How to weigh the route.
- 4 sources cited
Ozempic vs Wegovy: Same Drug, Two Different FDA Approvals
Ozempic and Wegovy are both semaglutide. What differs is the FDA-approved indication, the maximum dose, and a cardiovascular-risk claim only one carries.